Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia

Hyperuricemia has been identified as an independent risk factor for chronic kidney disease (CKD) and is associated with the progression of kidney diseases. It remains unknown whether enhancer of zeste homolog 2 (EZH2), a histone H3 lysine 27 methyltransferase, can regulate metabolism of serum uric a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Physiol Renal Physiol
Hlavní autoři: Shi, Yingfeng, Xu, Liuqing, Tao, Min, Fang, Lu, Lu, Jiasun, Gu, Hongwei, Ma, Shuchen, Lin, Tao, Wang, Yi, Bao, Wenfang, Qiu, Andong, Zhuang, Shougang, Liu, Na
Médium: Artigo
Jazyk:Inglês
Vydáno: American Physiological Society 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734054/
https://ncbi.nlm.nih.gov/pubmed/30566000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00234.2018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky